A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies
Thomas Jefferson University
Thomas Jefferson University
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
Thomas Jefferson University
PharmaEssentia Japan K.K.
Incyte Corporation
Roswell Park Cancer Institute
City of Hope Medical Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Queen's University, Belfast
Sierra Oncology LLC - a GSK company
M.D. Anderson Cancer Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
NS Pharma, Inc.
Hoffmann-La Roche
M.D. Anderson Cancer Center
Hoffmann-La Roche
CTI BioPharma
Roswell Park Cancer Institute
Novartis
Icahn School of Medicine at Mount Sinai
CTI BioPharma
M.D. Anderson Cancer Center
University of Oklahoma
Novartis
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Mayo Clinic
Italfarmaco
Italfarmaco
Roswell Park Cancer Institute
Italfarmaco
Novartis
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Icahn School of Medicine at Mount Sinai
Incyte Corporation
University of Illinois at Chicago
M.D. Anderson Cancer Center
Wake Forest University Health Sciences
Incyte Corporation
Fred Hutchinson Cancer Center
Incyte Corporation
OHSU Knight Cancer Institute
UNC Lineberger Comprehensive Cancer Center
Weill Medical College of Cornell University
Fred Hutchinson Cancer Center